| 000 | 01696 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517224832.0 | ||
| 264 | 0 | _c20181024 | |
| 008 | 201810s 0 0 eng d | ||
| 022 | _a1998-4138 | ||
| 024 | 7 |
_a10.4103/jcrt.JCRT_738_17 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Yong | |
| 245 | 0 | 0 |
_aConversion chemotherapy with capecitabine and oxaliplatin for colorectal cancer with potentially resectable liver metastases: A phase II, open-label, single-arm study. _h[electronic resource] |
| 260 |
_bJournal of cancer research and therapeutics _c2018 |
||
| 300 |
_a772-779 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCapecitabine _xadministration & dosage |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xpathology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aOxaliplatin |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLi, Guo-Xin | |
| 700 | 1 | _aChu, Zhong-Hua | |
| 700 | 1 | _aHao, Chun-Yi | |
| 700 | 1 | _aJiang, Zhi-Wei | |
| 700 | 1 | _aChen, Huan-Qiu | |
| 700 | 1 | _aLin, Jian-Jiang | |
| 700 | 1 | _aLi, De-Chuan | |
| 700 | 1 | _aHu, Bing | |
| 700 | 1 | _aWang, Xi-Shan | |
| 700 | 1 | _aLin, Feng | |
| 773 | 0 |
_tJournal of cancer research and therapeutics _gvol. 14 _gno. 4 _gp. 772-779 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4103/jcrt.JCRT_738_17 _zAvailable from publisher's website |
| 999 |
_c28596986 _d28596986 |
||